Skip to main content
Dr Layloma Rashid avatar
Reviewed profileID verifiedEEAT
StocksAI

TECHi author

Dr Layloma Rashid

News Writer

@layloma

Stories

416

419K total views

Author score

64

Profile reviewed

First story

July 23, 2025

Member since June 28, 2025

Connect

Dr Layloma Rashid brings a clinical lens to healthcare investing. She translates FDA filings, Phase 3 readouts, and PDUFA calendar dates into analysis readers can act on — covering large-cap pharma, medical-device makers, and the oncology and GLP-1 pipelines reshaping the sector. Her coverage weighs ClinicalTrials.gov data against management guidance and flags where sell-side models diverge from what trial design actually supports. She writes about drug development with the skepticism Phase 2 success rates deserve.

Sign in for alertsGet email alerts when Dr publishes new reports.

Track record

Quality & trust dashboard

Scores roll up from Dr Layloma Rashid's published work, editorial quality signals, and identity verification. All values 0-100.

Published

416

Articles on TECHi

Total views

418.9K

Across all work

Author ScoreBuilding
64/100

TECHi's composite score — blends output volume, community ratings, fact-check accuracy, identity verification, and profile completeness.

TrustNot measured

Reader trust score is shown after enough article-level votes exist. Until then, TECHi does not display a synthetic trust score.

Fact-checkNot measured

Fact-check score is shown only when reviewed article-level evidence exists. Empty means unmeasured, not failed.

EngagementNot measured

Engagement score appears once analytics-backed interaction data has been attached to this author.

OutputExcellent
100/100

Publishing cadence and volume normalized over time. Rewards consistent output without overweighting prolific drive-bys.

QualityPending review

Quality score is displayed after measurable trust or fact-check data exists. Verification alone does not create a quality score.

IdentityExcellent
100/100

Identity verified via standard ID check. Confirmed by TECHi.

Profile completenessBuilding
57/100

Filled profile sections: headline, bio, avatar, social links, expertise, location. Higher = better reader context.

Field confirmed

0

Facts that community fact-checkers reviewed and confirmed as accurate. A dash means this signal is not tracked yet.

⚠︎

Accepted corrections

0

Approved corrections tied to this author in TECHi's public corrections log. Zero means no approved public correction is on record.

Revisions shipped

0

Post-publish updates the author submitted and an editor approved. Signals active stewardship of evergreen content.

TECHi Reviewed Author ProfileID VerifiedE-E-A-T profile complete

Author profile

Editorial output from Dr Layloma Rashid

Articles

416

Views

418.9K

Score

64

Latest

Jul 19, 2026

Since Jul 23, 2025

Beat map

Markets & Equities9
AI & Intelligence6
Tech Breakthroughs2
Crypto & DeFi1

Publishing cadence

Output over 12 months

18 articles across 5 active months.

11
1
3
1
2
AugSepOctNovDecJanFebMarAprMayJunJul

Lead story

Most recent publish - open the full analysis or scroll for the full archive.

Archive

Latest analysis

Stocks, crypto, AI, and policy - reporting and commentary on TECHi (showing 18 of 307).

Legacy archive

Pre-pivot work

7 articles from Dr Layloma Rashid's earlier editorial era on TECHi. These remain available at their original URLs but aren't part of the current beat.

Topic mix

Coverage breakdown

Where Dr's recent stories cluster — jump into a desk.